News
Through their research programs, the 2026 fellows are advancing new tools and insights to inform conservation strategies, strengthen disease management, and promote sustainable systems that benefit wildlife, people, and the planet.
Satellite-derived maps of defoliation caused by European spongy moths offer a promising solution for tracking pest outbreaks and for identifying large scale trends.
Strict regulations have prevented continental U.S. beekeepers from participating in the lucrative organic honey market, but new findings could provide evidence to open organic markets to U.S. producers.
Researchers studying ribosomes, AI and quantum computing are among 13 early-career professors from Cornell who’ve recently been awarded National Science Foundation Faculty Early Career Development Awards.
A new model offers a proof-of-principle for how AI might be used to shed light on obscure biological processes.
People may not only need specific species of gut bacteria but also the right strains of those bacteria to benefit from dietary fiber.
As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to NSE-FAST®, the first rapid blood test designed to aid in the diagnosis of acute ischemic stroke.
Tree swallows in the northern U.S. and Canada face the greatest risk from climate change despite responding to temperature the same way as tree swallows in the southern U.S.
A Cornell-led study is challenging a decades-old explanation for how chromosomes exchange genetic material within the biological process that forms eggs and sperm in mammals.
A $13.3 million grant from the NIH will support efforts to reveal how immune cells communicate within living tissues, which could shape new approaches for treating inflammatory diseases, autoimmune disorders and infections.
